Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals

NCT00973375 | Unknown

• 1 other identifier: LHQ09-003
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.

Conditions

Drug Eluting Stent

Keywords

Drug-eluting stent; coronary restenosis; coronary thrombosis

Outcome Measures

Primary Outcomes (1)

• Segment and instent restenosis measured by coronary angiography and IVUS.

  at 12 months after implantation

Secondary Outcomes (1)

• Uncovered and malposition of stent.

  at 12 months after implantation.

Study Arms (1)

Endeavor group and Excel group

Endeavor group: measurements from the vessels implanted Endeavor stent(s). Excel group: measurements from the vessels implanted Excel stent(s).

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

You may qualify if:

• These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

You may not qualify if:

• Dual anti-platelet therapy less than 12 months.

Sponsors & Collaborators

• Liuhuaqiao Hospital: lead

Study Sites (1)

Liuhuaqiao Hospital

Guangzhou, Guangdong, 510010, China

RECRUITING

Related Publications (3)

• Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015.

  PMID: 19695548 BACKGROUND

• Lee CH, Zhang J, Kailasam A, Tai BC, Ye F, Low AF, Hou X, Hay ET, Teo SG, Lim YT, Chen S, Tan HC. An intravascular ultrasound study of Cypher, Taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden. J Interv Cardiol. 2008 Dec;21(6):519-27. doi: 10.1111/j.1540-8183.2008.00397.x. Epub 2008 Oct 21.

  PMID: 18973509 BACKGROUND

• Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ; ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Am Heart J. 2008 Jan;155(1):108-13. doi: 10.1016/j.ahj.2007.08.008. Epub 2007 Sep 14.

  PMID: 18082499 BACKGROUND

MeSH Terms

Conditions

Coronary Restenosis; Coronary Thrombosis

Condition Hierarchy (Ancestors)

Coronary Stenosis; Coronary Disease; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Thrombosis; Embolism and Thrombosis

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: September 8, 2009
• First Posted: September 9, 2009
• Study Start: May 1, 2009
• Last Updated: September 9, 2009

Record last verified: 2009-09

Locations

CN (1)